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The mechanism whereby sulfanilamide and its derivatives prevent bacterial 
growth is not known.  None of the various theories advanced (1-3) has been 
conclusively substantiated by direct experimental proof.  The most important 
recent contribution to the problem has been that of Woods (4), who demon- 
strated that p-aminobenzoic acid "blocks" the bacteriostatic effect of sulfanil- 
amide in vitro.  Following the isolation by Stamp (5) and Green (6) of bac- 
terial extracts which antagonize the action of sulfanilamide, Woods obtained 
from yeast a potent antisuLfanilamide factor which appeared to have chemical 
properties similar to p-aminobenzoic acid but which could not be definitely 
identified as such.  p-Aminobenzoic acid  itself was  found to annul  the bac- 
teriostatic effect of sulfanilamide, and Woods predicted that this simple organic 
acid  would  eventually l:e  shown  to  be  a  metabolite  essential  for bacterial 
growth3  He also formulated the theory that sulfanilamide causes bacterio- 
stasis by inhibiting specifically the enzymatic reaction involved in the utiliza- 
tion of p-aminobenzoic acid and attributed the inhibition of this reaction to 
the chemical similarity of the drug and the essential metabolite. 
Important evidence supporting Woods' hypothesis was published in the same 
year by Rubbo and Gillespie (8).  They reported the chemical isolation from 
* This study was supported in part by a grant from The Rockefeller Foundation 
Fluid Research Fund. 
x To prove a  substance essential to bacterial metabolism it is necessary first to 
demonstrate that it is a growth factor for at least one bacterial species.  A growth 
factor may be defined as an essential metabolite which cannot be synthesized by the 
bacterial cell and which, therefore, must be added to the culture medium to promote 
optimal growth.  According  to  views  first  introduced by  Fildes  (7),  substances 
known to be bacterial growth factors for one or more species of organism  may be 
considered  to be metabolites essential for the growth of many other bacteria and 
probably of bacteria in general. 
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yeast of the benzoyl derivative of p-aminobenzoic acid and stated in addition 
that p-aminobenzoic acid stimulated the growth of Clostridium acetobutylicum 
in  a  synthetic  medium.*  Their  observations  led  them  to  conclude  that 
p-aminobenzoic  acid is a  bacterial growth factor and, therefore,  an essential 
metabolite.  They pointed out, however,  that in their experiments  with Cl. 
acetobutylicum  one molecule of p-aminohenzoic acid antagonized 23,000 mole- 
cules of sulfanilamide.  This tremendous disproportion  between  the antago- 
nistic  substances  was interpreted as strong evidence  against Wood's theory 
that the  drug and  the essential  metabolite compete  for the same receptor 
site on the organism. 
The data reported in the present paper concern the quantitative aspects of 
the antagonistic action of p-aminobenzoic acid and the more commonly used 
sulfonamide drugs.  A detailed study of the quantitative relationship  between 
p-aminobenzoic  acid  and  the  bacteriostatic  effect  of  sulfanilamide,  sulfa- 
pyridine,  sulfathiazole,  sulfadiazine,  sulfaguanidine,  and  diaminodiphenyl- 
sulfone has been carried out under rigidly controlled conditions in an attempt 
to ascertain the manner in which  p-aminobenzoic  acid interacts with these 
different sulfonamide drugs,  It was hoped that knowledge of this interaction 
might lead to a dearer understanding of the mechanism of bacteriostasis  and 
might possibly suggest an explanation for the marked differences in bacterio- 
static potency eXhibited by the various derivatives of sulfanilamide. 
Materials and Methods 
MacLeod  (11) has  demonstrated  the  widespread  occurrence  of .sulfon- 
amide  inhibitors  in 'ordinary  bacteriological  media,  and  has  stressed  the 
importance  of  using  inhibitor-free  media in studying the effect  of sulfon- 
amide drugs upon bacteria in ~itro.  Bacterium  coli  was used in the present 
studies since it will grow luxuriantly in an inhibitor-free  medium containing 
only asparagine as a source of nitrogen, glucose as a source of carbon, and inor- 
ganic salts.  The addition of p-aminobenzoic acid to the medium in concentra- 
tions corresponding  to those used in the following experiments  had no effect 
upon the growth of the organlSm as tested by repeated growth curves.  Th~s 
fact is of primary importance since the antibacteriostafic effect of compounds 
which  stimulate growth cannot be  attributed to a  specific action upon the 
drug; their effect  may be due entirely to a  non-specific stimulation of the 
growth of the organism, s 
*  In attempting to confirm the important findings 9f Rubbo and Gillespie, both 
Lampen and Peterson (9)  and Park  and Wood (10) demonstrated independently 
that p-aminobenzoic  acid will function as a growth factor for Cl. acetebutylicura only 
in the presence of biotin; 
s The non-specific effect of growth-stimulating substances is well illustrated  by 
experiments reported in the next paper (12). W.  BARRY WOOD~ JR.  371 
Culture Medium.--The synthetic medium used was prepared in the following man- 
ner (13).  5  gin. of NaC1, 2  gin. of K2HPO4, 0.5 gin. MgSOn, 2  gin.  of ammonium 
citrate, and 3.5 gin.  of asparagine were added to  1000  cc. of distilled water which 
had been brought to a  boil.  After being cooled the mixture was adjusted to a  pH 
of 7.6 with sodium hydroxide (3 to 5 cc. of 2 normal NaOH), and was sterilized in the 
autoclave.  0.1  cc. of a  10 per cent solution of dextrose was added to the 10 cc. of 
basal medium in each tube before inoculation.  The dextrose solution was sterilized 
by being heated to boiling for 5 minutes.  Both the dextrose solution and the basal 
medium were stored in the ice box. 
Strain of B. coli.--The strain of B. coli communior employed in the present ex- 
periments was obtained through the courtesy of Dr. Eleanor A. Bliss of the Depart- 
ment of Preventive Medicine of the Johns  Hopkins Medical School.  The organism 
was originally isolated from the urine of a patient with pyelitis.  Daily subcultures 
were made in synthetic medium and these cultures were used as the source of organism 
in each experiment.  The growth obtained in the synthetic medium was remarkably 
constant. 
Inoculum.--In all experiments the inoculum employed was 0.1  cc. of a  1:10,000 
dilution of a 24 hour culture of B. coli in synthetic broth.  The inoculum, as estimated 
by plate count, contained approximately 10,000 viable organisms. 
Preparation of Stock Solutions of Sulfonamide  Drugs  and p-Aminobemoic  Acid.- 
In 200 cc. lots of sterile basal medium sulfanilamide and sulfaguanidine were dissolved 
in  concentrations of 0.01  molar, and sulfapyridine, sulfathiazole, sulfadiazine, and 
diaminodiphenylsulfone were prepared in 0.001 molar concentrations.  The powdered 
drug was added in each case to boiling medium and the solution was allowed to cool 
slowly.  The maximum concentration of each drug used was limited by its solubility 
in  the  basal  medium.  0.001  molar  p-aminobenzoic acid in  synthetic  broth  was 
prepared by the same procedure. 
Method of Titration.--The antagonistic action of p-aminobenzoic acid to each sul- 
fonamide drug was studied quantitatively by titrating the acid against the  drug, 
the appearance of bacterial growth being used as an arbitrary end point.  The desired 
concentrations of the antagonistic substances were attained by adding appropriate 
amounts of the stock solution of each to plain synthetic broth to make a final volume 
of 10 cc.  0.1  cc. of 10 per cent glucose was added to each tube just before it was 
inoculated.  The  tubes were examined at daily intervals for macroscopic evidence 
of bacterial growth and the final readings were made at the end of 5 days.  All cultures 
were incubated at 37°C. 
RESULTS 
Data from a  typical titration experiment are recorded in Fig. 1.  It will be 
noted  that  over  a  relatively wide  range  of sulfapyridine concentrations  the 
minimum amount of p-aminobenzoic acid needed to prevent bacteriostasis at 
the end of 5 days was such that the ratio of p-aminobenzoic acid to su]/apyridine 
was  approximately constant.  4  As  the  concentration  of drug  was  decreased, 
* A  constant  ratio of p-aminobenzoic acid to  each sulfonamide drug was noted 
also at end points determined after 48, 72, and 96 hours as well as at the end of 5 
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however, a  point was  finally reached where  the  ratio  changed  and  rapidly 
approached  zero.  This  sudden  bend  in  the  titration  curve  was  obviously 
caused by the drug level's approach to the minimum concentration of sulfa- 
pyridine needed to cause bacteriostasis in the basal medium, and it in no way 
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FIG.  1. Titration of  p-aminobenzoic  acid  against  sulfapyridine using  bacterial 
growth as an arbitrary end point.  +  =  visible growth of B. coli in 10 cc. of a syn- 
thetic medium within 5 days of inoculation.  Standard inoculum employed  was 10,000 
organisms.  Cultures incubated at 37°C. 
invalidates the linear relationship exhibited at higher concentrations.  In the 
subsequent discussion of titration curves, therefore, only those points will be 
considered at which the drug level is well above the minimum bacteriostatic 
concentration. 
The data summarized in Table I reveal a similar linear relationship between 
p-aminobenzoic acid  and  each  of  the  sulfonamide  compounds  studied,  the 
ratio of p-aminobenzoic acid to drug remaining approximately constant over TABLE  I 
Quantitative Study of the Antagonistic Action of p-Aminobenzoic Acid upon 
Various 8ulfonamide Drugs 
Sulfonamide drug 
S~a~a~de 
Concentration (molar) 
Sulf.  drug 
Concentration (molar) 
P.a.b.a. needed to 
prevent bacteriostasis 
... Molar cone. P.a.b.a. 
~o.  M~  ~ 
9  X  10-  a 
7  X  10  -a 
5  X  10  -3 
3  X  10--  s 
2  X  10-  3 
1  X  10-  3 
6  X  10-  3 
4X  10  -~ 
3X  10-  6 
2X  10-  6 
1X10 ~ 
7  X  10-  7 
6.7  X  10-' 
5.7  X  10  -~ 
6.0  X  10-4 
6.7  X  10-' 
5.0X  10-4 
7.0  X  10-' 
Average ratio .....  6.2  X  10-' 
Diaminodiphenyl- 
sulfone 
9X  10  ~ 
8  X 10  4 
7X  10-4 
6  X  10-' 
5  X  10-' 
4  X  10' 
6  X  10-  7 
6  X  10-  7 
5  X  10-  7 
5  X  10-  7 
3  X  10-  7 
3  X  10-  7 
6.7  X  10-' 
7.5X  10--4 
7.1  X  10-' 
8.3 X  10  -~ 
6.0X  10"-' 
7.5X  I0-' 
Average ratio .....  7.2  X  10  -4 
Sulfaguanidine  9  X  10  -s 
5  X  10  -s 
2  X  10  -3 
1  X  10-  s 
5  X  10-' 
X  10-~ 
X  10  4 
X  10  4 
X  10  4 
X  10-  7 
1.1  X  10  -8 
1.0 X  10  -s 
1.0 X  10-  s 
1.0 X  10  -s 
1.0  X  10  -a 
Average ratio .....  1.0 X  10  -a 
Sulfapyridine  9  X  10-' 
5  X  10-' 
2  X  10-' 
1  X  10-' 
5  X  10  -6 
1 X  10  -6 
5  X  10  -6 
2  X  10-  6 
1 X  10  4 
5  X  10-  7 
1.1  X  10  -2 
1.0 X  10-  2 
1.0  X  10  ~ 
1.0  X  10-  2 
1.0  X  10-  2 
Average ratio .....  1.0  X  10-  s 
Sulfadiazine  9  X  10--~ 
5X10  ~ 
2  X  10-' 
1 X  10  -~ 
5  X  10-  5 
1 X  10  -5 
5×10-  6 
2X10  ~ 
1 ×  10  -6 
5  X  10-  7 
1.1  X  10  4 
1.0  X  10--2 
1.0X  10  ~ 
1.0X  10  's 
1.0X  10  ~ 
Average ratio .....  1.0 X  10  -~ 
Sulfathiazole  9  X  10-' 
7  X  10-' 
5  X  10-' 
3  X  10-' 
2  X  10"  ~ 
1 X  10-  4 
8  X  10-  6 
3  ×  10  -5 
2  X  10  -5 
1 X  10  4 
7  X  10  4 
5  ×  I0-~ 
3  X  10  -~ 
3X  10  -~ 
3.0 X  10  ~ 
2.9X  10  -~ 
2.0 X  10  4 
2.3  X  10  -~ 
2.5  X  10  -'s 
3.3  X  10  4 
3.7X  10  ~ 
Average ratio .....  2.8 X  10  ~ 
Sulf.---sulfonamide. 
P.a.b.a.--p-aminobenzoic  acid. 
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the range of each titration experiment. 
mathematically as follows: 
(i)  (P.a.b.a.) 
(Sulf.) 
This relationship may be expressed 
K 
or 
(2)  (P.a.b.a.)  =  K  (Sulf.) 
in which (P.a.b.a.)  =  molar concentration of p-aminobenzoic acid. 
(Sulf.)  =  molar concentration of sulfonamide drug. 
g  =  a constant. 
Equation (2) plotted on Cartesian coordinates represents a  straight line, with 
slope K, passing through the origin.  Since the absolute values for K (as shown 
in Table I) are extremely small, the titration curves cannot be conveniently 
plotted arithmetically, their slopes being so small that they practically lie upon 
the x axis.  The results of each titration experiment can, however, be graphed 
on a logarithmic scale as shown in Fig. 2.  It will be noted that the data thus 
plotted fall on straight lines parallel to one another and running at an angle 
of 45 ° with the axis.  These lines all approximate very closely the general 
equation: 
(3)  log (P.a.b.a.)  =  log (Sulf.)  -[- log K 
which will be recognized as the logarithmic variant of equation (2) expressing 
the same linear relationship between drug and p-aminobenzoic acid. 
Two  facts  regarding  the  significance of  the  constant  K  deserve  special 
emphasis: 
(a)  The constant is equal to the molecular ratio of p-aminobenzoic acid and 
sulfonamide drug at the arbitrary end point chosen for the titration experi- 
ments.  Under standard conditions it defines the amount of p-aminobenzoic 
acid needed to nullify the antibacterial effect of a given quantity of drug. 
(b)  The absolute value of K  will vary with the type of organism, the size 
of the inoculum, the conditions under which the organism is grown, and the 
potency of the  bacteriostatic agent employed.  If all but  the last of these 
variables is kept rigidly constant, as in the present experiments, the magnitude 
of K  becomes an index of the relative bacteriostatic power of the drug tested. 
Under  these  conditions it is justifiable to refer to K  as the  "bacteriostatic 
constant." 
As shown in Table II the bacteriostatic constants of the various sulfonamide 
compounds vary over a relatively wide range of values.  It will be noted that 
the more potent the drug the greater is the value of its bacteriostatic constant 
K, and, likewise,  the lower its p-aminobenzoic acid titration curve falls on the W. BARRY WOOD, JR.  375 
logarithmic graph (Fig. 2).  Thus the bacteriostatic constant of sulfathiazole, 
the most potent drug studied, is 0.028, whereas that of sulfanilamide, the least 
active, is only,0.00062. 
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FIG.  2. p-Aminobenzoic  acid  titration  curves  of  sulfonamide  drugs.  Visible 
growth of B. coli  (in 10 cc. of a synthetic medium) used as arbitrary end point for 
each titration.  Inoculum standardized at 10,000 organisms and final readings made 
at the end of 5 days incubation at 37°C.  Curves plotted for convenience on logaxith- 
mic coordinates. 
Tt is of interest to compare the relative values obtained for K  with the bac- 
teriostatic potency of the drugs measured by the usual method, i.e. by deter- 
mining  the  minimum  concentration  needed  to  cause  bacteriostasis  in  the 
absence of additional p-aminobenzoic acid.  The two sets of values may best 
beCompared by using sulfanilamide as a standard and determining the "sulf- 
anilamide coefficient" as shown in Table iI.  The data reveal a remarkably 
dose correlation between the sulfanilamide coefficients determined by the two 376  ANTIBACTERIAL  ACTION  Ol  • SULFONAM~DE  DRUGS.  I 
methods.  5  This  close  correlation  is  of  considerable  theoretical  significance 
since it  suggests that  the  bacteriostatic potency of each of the  sulfonamide 
compounds is directly proportional to its ability to neutralize the action of the 
p-aminobenzoic acid added to the culture medium. 
In summary it may be stated that a quantitative study of the interaction of 
various sulfonamide drugs with p-aminobenzoic acid has revealed the following: 
The antibacterial effect of each sulfonamide compound studied, regardless of 
chemical structure, was neutralized by the addition of p-aminobenzoic acid to 
the culture medium.  The amount of p-aminobenzoic acid needed to prevent 
TABLE II 
Sulfanilamide  Coeffwients of Various Sulfonamide  Drugs Determined Both by Measuring ths 
Minimum Bacteriostatic Concentration and by Titrating with p-Aminobenzoic 
Acid 
Sulfonamide  drug 
Sulfanilamide .............. 
Dlaminodiphenylsulfone  ..... 
Sulfaguanidine ............. 
Sulfapyridine  ............... 
Sulfadiazine ................ 
Sulfathiazole ............... 
Minimum 
molar conc. of 
drug  causing 
bacteriosta.sis 
0.0004 
0.0002 
0.0002 
0.00002 
0.00002 
0.000008 
Bacteriostatic 
constant,  K  or 
Molar conc. Pa.b.a. 
Molar conc. Sulf. 
(P.a.b.a. titration) 
0.00062 
0.00072 
0.001 
0.01 
0.01 
0.028 
Sulfanilamide  coefficients 
Min. bact.  conc. S.  Ks 
Min. bact. conc. X.  K. 
1  1.0 
2  1.2 
2  1.6 
20  16.1 
20  16.1 
50  45.2 
K, bacteriostatic constant determined by titration  with P.a.b.a.  (See  average ratios, 
Table  1.) 
P.a.b.a.,  p-aminobenzoic acid. 
Surf.,  sulfonamide drug. 
Min. hact. conc. S., minimum molar concentration of sulfanilamide causing bacteriostasis. 
Min. bact. conc.  X., minimum molar  bacteriostatic concentration  of sulfonamide drug being 
compared with sulfanilamide. 
K,, bacteriostatic constant  of  sulfanilamide. 
K,, bacteriostatic constant of sulfonamide drug being compared with sulfanilamide. 
bacteriostasis was directly proportional to the relative  bacteriostatic  potency 
of the drug.  Over a wide range of drug concentrations the minimum amount 
5  The p-aminobenzoic  acid titration  method is  considered  the more accurate of 
the two since the absolute  value for K is obtained by averaging  the numerous  end 
points on the titration curve rather than by determining  a single end point as in the 
simple  becteriostasis  method.  It should  be  emphasized,  however,  that neither of 
these in vitro methods can be relied upon at present to estimate the relative therapeu- 
tic effectiveness of untried sulfonamide  compounds.  The sulfanilamide  coefficients 
listed  above have been measured  under highly specialized conditions, namely, in an 
inhibitor-free  medium;  it does not necessarily follow that the relative  bacteriostatic 
potency of the drugs will be the same in a more complex culture medium or in the 
animal body. W. BARRY WOOD, JR.  377 
of p-aminobenzoic acid needed to nullify the bacteriostasis was such that the 
ratio of p-aminobenzoic acid to the drug was constant.  The p-aminobenzoic 
acid titration curve for each sulfonamide drug thus followed a linear relation- 
ship.  The implications of these facts in relation to the possible mode of action 
of the sulfonamide drugs are considered significant and will be discussed below. 
DISCUSSION 
The important investigations of Woods on the mechanism of action of sulf- 
anilamide were based on the working hypothesis that "antibacterial substances 
act by interfering with some substance essential to the bacterial cell."  Having 
demonstrated that p-aminobenzoic acid in minute quantities neutralized the 
bacteriostatic effect of sulfanilamide and sulfapyridine, Woods suggested that 
the essential substance was p-aminobenzoic acid or a closely related compound. 
It is noteworthy, however, that at the time of his publication there was no direct 
experimental  evidence  that  p-aminobenzoic  acid  was  essential  to  bacterial 
metabolism, this evidence being supplied later by workers in other laboratories 
(8-10).  Woods suggested  further that  sulfanilamide  and  sulfapyridine, be- 
cause of their close chemical similarity to p-aminobenzoic acid, prevent bac- 
terial growth by competing with the latter compound for the bacterial enzyme 
normally involved in its utilization.  As evidence for this concept, he pointed 
out that the slightest deviation from the chemical structure of p-aminobenzoic 
acid greatly reduces the potency of the  antisulfonamide effect, just  as any 
change in the p-amino structure of sulfanilamide decreases its bacteriostatic 
properties.  In addition he drew attention to other examples in enzyme chemis- 
try of "competitive inhibition" due apparently to similarity of chemical struc- 
ture.  It should be emphasized that Woods' experimental data did not con- 
clusively prove his  theory which  was  presented only as a  guide  to further 
investigation. 
The results of the studies reported in the present paper add important direct 
evidence in favor of Woods' theory.  It  was  observed that  p-aminobenzoic 
acid would neutralize the bacteriostatic properties of all of the six sulfonamide 
compounds studied,  regardless of the differences in their chemical structure, 
and it was found also that the amount of p-aminobenzoic acid needed to pre- 
vent bacteriostasis was directly proportional to the bacteriostatic potency of 
the  drug,  provided all  other  variables  were held  constant.  Both  of  these 
observations suggest  that  the  bacteriostatic mechanism  s of the  sulfonamide 
e It is of interest that the sulfonamide portion of the molecule rather than the p- 
amino nucleus, appears to be responsible for certain of the toxic reactions caused by 
these drugs.  The -SO2NH2 radical of sulfanilamide inactivates carbonic anhydmse 
(14), and this fact has been offered as an explanation for sulfanilamide acidosis (15). 
Patients becoming sensitive to one sulfonamide  drug are often found insensitive  to 
others (16), an observation suggesting that the sensitivity phenomena are caused  by 
some part of the molecule other than the p-amino nucleus which is common to all of 
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drugs  works mainly,  if not  entirely,  through  the  p-amino  nucleus  which  is 
common to p-aminobenzoic acid and to all of the drugs tested.  The fact that 
an organism made "drug fast" to sulfathiazole is found to be resistant to the 
action of other suifonamide compounds  (17)  also substantiates this concept. 
In addition, the quantitative study of the interaction of p-aminobenzoic acid 
and the various sulfonamide drugs in bacterial cultures revealed that over a 
wide  range of drug  concentrations  the  minimum amount of p-aminobenzoic 
acid needed to prevent bacteriostasis was such that the ratio of p-aminobenzoi  c 
acid to drug remained constant.  Woods previously had observed, in similar 
experiments, a  constant ratio of p-aminobenzoic acid to drug when sulfanil- 
amide was added to cultures of B. coli or Streptococcus hemolyticus, and while 
the  present  work  was  in  progress  Rubbo  and  Gillespie  reported  the  same 
observation with sulfanilamide and Cl. acetobutylicum.  In none of those experi- 
ments, however, were drugs other than sulfanilamide  investigated. 7 
The linear relationship between drug and p-aminobenzoic acid is of consider- 
able theoretical significance since it suggests that bacteriostasis is accomplished 
through the "competitive inhibition" (19) of an essential enzyme reaction by a 
substance chemically related to the substrate.  Assuming the substrate to be 
p-aminobenzoic acid (or a  closely related compound) and the inhibitor to be 
the suifonamide drug, an equation expressing the same straight-line relationship 
may be derived on purely theoretical grounds as follows: 
If p-aminobenzoic acid (P) and sulfanilamide, or one of its derivatives (S), compete 
for the same bacterial enzyme (E), the interaction of P  and S  with E  may be ex- 
pressed by the equations: 
(t)  P+E~P~  (2)  S+E~-SF. 
Since  the concentrations of P  and S  are infinitely large compared to that  of  E,  s 
it may be assumed that practically all of the available enzyme is bound either by P 
or S and, therefore, may be considered to be equivalent to (PE) + (SE).  The amount 
of available enzyme is constant at the start of each experiment (constant inoculum 
of  bacteria),  so  that 
(3)  (w) +  (s~)  =  k, 
7 Strauss, Lowell, and Finland (18) studied sulfanilamide, sulfapyridine, and sulfa- 
thiazole, and although they concluded that a linear relationship existed between drug 
and inhibitor, their data do not bear out this conclusion, since the curve obtained for 
each drug is a straight line only when plotted on semilogarithmie coordinates. 
s The concentration of P  and S ranged from 1 to 10  -5 rag. per ce., whereas the 
concentration of bacteria introduced in the inoculum was 1,000 organisms (or ap: 
proximately 10 to 12 rag.) per cc.  Even if it is assumed that the entire bacterial cell 
functions as active enzyme and that the relatively small p-aminobenzoic acid and 
sulfonamide molecules combine weight for weight with the much larger enzyme mole- 
cule, there is still a tremendous discrepancy between the amount of available enzyme 
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The ability of the organism to multiply depends upon a certain minimum amount of 
p-aminobenzoic acid combining with enzyme to form the essential complex PE.  At 
the selected titration end point only the minimum amount of P/~ needed to initiate 
growth is present at the start of the experiment, and, therefore, at this point (PE) 
may be considered a  fixed quantity, k2.  It follows that 
(4)  (PE)  =  k, 
and 
(s)  (SE) = kl - k, 
At the titration end point the proportions of enzyme bound by P  and S at the start 
of each experiment will be determined by two factors:  (a) the relative affinities  of 
P  and S for the enzyme, E, and (b) the relative amounts of P  and S in the medium. 
The affinities of P  and S for the enzyme are determined by the chemical properties 
of the compounds and may be considered constant in any one experiment, although 
the  enzyme affinities  of the  different sulfonamide drugs probably vary with  their 
chemical structure (12).  It follows then that the relative concentrations of PE and 
SE are directly proportional to the relative  concentrations of P  and S.  That is, 
(PE) =. k8 (P)  (6)  (s-5 
and 
(7) 
(P)  k, 
(S)  k,(kl  --  k,) 
Since (PE) and (SE) are infinitely small as compared with  (P) and (S), the terms 
(P) and (S) may be considered equivalent to the total amounts of p-aminobenzoic 
acid (P.a.b.a.) and sulfonamide drug (Sulf.)  added to the medium. 
(P.a.b.a.) 
(8)  (SuU.)  K 
The last  equation given expresses  precisely  the linear  relationship  observed 
experimentally.  The close  agreement between the theoretical  equation and 
the experimental data adds strong  evidence in  favor of  the assumption that the 
sulfonamide drugs and p-aminobenzoic acid  compete for the same enzyme site 
on the bacterial  cell2 
If  p-aminobenzoic acid is  essential  for  bacterial  growth, and the sulfonamide 
drugs, through their  chemical similarity  to this  essential  metabolite,  succeed 
in  blocking thc  enzyme system normally involved in  its  utilization,  it  obviously 
follows  that  the  bacteria  will  not  grow.  The fact  that  one  molecule of  p-amino- 
benzoic acid  will  antagonizc the action of several  thousand molecules of drug 
9  Since  the completion  of this  manuscript Wyss (20)  has published  similar  experi- 
ments with p-aminobenzoic acid  and sulfanilamide  and has reached the same con- 
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does not invalidate this theory as to the mechanism of bacteriostasis; it may 
only indicate that  the essential metabolite has a  far greater affinity for the 
enzyme than has the drug, in which case a great excess of drug will be required 
to block the essential metabolite from its bacterial enzyme.  The well known 
lag in the bacteriostatic action of the drug (21) may be explained by assuming 
that the supply of p-aminobenzoic acid already in the medium (and possibly 
combined with bacterial enzyme) must become inadequate before the rate of 
bacterial growth will be noticeably affected. 
In conclusion it should be emphasized that although the experiments reported 
in the present paper strongly substantiate Woods' theory as to the mechanism 
of action of the sulfonamide drugs, the final proof of the theory must await the 
identification and careful study of the enzyme system (or systems) involved in 
the utilization  of p-aminohenzoic acid. 
SUMMARY 
The following observations have been made which substantiate the theory 
that the sulfonamide drugs used in the treatment of bacterial infections exert 
their bacteriostatic effect by competing with the essential met~bolite, p-amino- 
benzoic acid, for an important enzyme site on the bacterial cell. 
1.  p-Aminobenzoic  acid was shown to nullify the bacteriostatic effect of all 
of the six sulfon~xide compounds studied even though the  drugs exhibited 
marked differences in chemical  structure. 
2.  The  bacteriostatic potency of each sulfonamide  drug was found to be 
directly proportional to its ability to counteract the antibacteriostatic action 
of p-aminobenzoic acid. 
3.  In the case of each drug tested over a wide range of concentrations the 
minimum  amount  of p-aminobenzoic  acid  needed  to  prevent  bacteriostasis 
was such that the ratio of p-aminobenzoic acid to drug was constant. 
4.  The linear relationship between p-aminobenzoic acid and drug was inter- 
preted as indicating the competitive inhibition of an essential enzyme reaction 
by a  substance chemically related to the substrate.  This interpretation was 
supported by the fact that the equation derived on purely theoretical grounds 
relating drug and acid expressed the same linear relationship as that observed 
experimentally. 
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